AROMASIN® (exemestane tablets) Important Safety Information
Scroll for Important Safety Information and Indication
Important Safety Information
Do not take AROMASIN® (exemestane tablets) if you are allergic to AROMASIN or to anything in it. The active ingredient is exemestane. Do not take AROMASIN if you are pregnant or if you might become pregnant as it may cause birth defects or miscarriage. If you become pregnant while taking AROMASIN, talk to your doctor immediately to learn about the potential risks to the baby. Do not take AROMASIN if you still have menstrual periods. AROMASIN is only for women who are past menopause.
Let your doctor know if you are taking or applying any medication that has estrogen in it, or if you are taking any other medicines or supplements as they can affect how well AROMASIN works.
A serious side effect of AROMASIN is bone loss over time that may increase your risk of osteoporosis and bone fractures. The health of your bones should be carefully monitored by your doctor for any bone loss before and during treatment with AROMASIN. Any bone loss should be treated appropriately.
Before starting to take AROMASIN, have your blood levels checked for Vitamin D deficiency. This is a common condition in women with early breast cancer and should be treated with Vitamin D supplements.
A small number of women had chest pain, heart failure or stroke while taking AROMASIN.
Common side effects of AROMASIN in women with early breast cancer were hot flushes, feeling tired, joint pain, headache, difficulty sleeping and increased sweating. Common side effects of AROMASIN in women with advanced breast cancer were hot flushes, nausea, feeling tired, increased sweating and increased appetite.
Tell your doctor if you have liver or kidney problems.
AROMASIN has risks and benefits. There may be other options. Talk to your doctor to learn more.
AROMASIN® (exemestane tablets) is a prescription medicine for:
Early breast cancer: AROMASIN is indicated for the adjuvant treatment (additional treatment given after the primary or main treatment) of postmenopausal women with estrogen-receptor positive (ER positive) early breast cancer. If switching to AROMASIN, treatment with AROMASIN should begin 2 to 3 years after tamoxifen, at which time tamoxifen should be stopped. Treatment with AROMASIN should continue for 2 to 3 years until a total of 5 years of adjuvant treatment of tamoxifen and AROMASIN have been completed.
Advanced breast cancer: AROMASIN is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed after tamoxifen therapy.
Patients should always ask their doctors for medical advice about adverse events.
You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where health care professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088.
*Terms and conditions
By using the AROMASIN Savings Card (the "Card"), you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:
The Card is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare or other federal or state healthcare programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico [formerly known as "La Reforma de Salud"])
The Card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs
With the Card you may pay as low as $4 per prescription of AROMASIN for a maximum savings of $300 per 30-day fill. The offer can be used once per month. Patients can receive a maximum savings of $3,600 per year
You must deduct the value received under this program from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf
The Card is not valid for Massachusetts residents whose prescriptions are covered in whole or in part by third-party insurance, or where otherwise prohibited by law
This program cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
The Card will be accepted only at participating pharmacies
This Card is not health insurance. Offer good only in the U.S. and Puerto Rico. The Card is limited to 1 per person during this offering period and is not transferable
Pfizer reserves the right to rescind, revoke, or amend the program without notice. No membership fees. Card and Program expire 12/31/2017
To learn more about the AROMASIN Savings Card, visit www.AROMASIN.com, call 1-866-562-6151 or write to: Pfizer Inc, PO Box 29387, Mission, KS 66201-9618
*For the AROMASIN Savings Card, terms and conditions apply. Click here. Offer is not health insurance and is only accepted at participating pharmacies. No membership fees.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.